Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
3839.HK
STRONG BUYREMOVEChia Tai Enterprises International Limited · Healthcare · Hong Kong · $255M · Avg Vol: $175K/d
Chia Tai Enterprises is a small-cap investment holding company focused on veterinary drugs and industrial equipment. It lacks scale, liquidity, and a clear thematic driver.
COMPANY DESCRIPTION
Chia Tai Enterprises International Limited manufactures and sells veterinary products, primarily chlortetracycline, and distributes industrial equipment in China. As a subsidiary of the Charoen Pokphand Group, the company leverages global distribution networks and strong brand recognition in the agricultural sector. It holds a leading market position in the global animal health market for feed-additive antibiotics.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 20.3M | 22.2M | 39.3M | 68.4M | 49.9% |
| EPS | -0.00 | 0.00 | 0.01 | 0.02 | 253.9% |
| Shares | 240.7M | 240.7M | 240.7M | 240.7M | 0.0% |
| Debt | 6.3M | 10.0M | 8.8M | 6.1M | -0.8% |
| Equity | 29.4M | 29.1M | 29.9M | 35.4M | 6.3% |
| Op CF | 0.7M | -2.0M | 1.4M | 4.4M | 82.7% |
| Inv CF | -2.0M | -0.9M | -1.2M | -0.4M | — |
| Fin CF | 1.3M | 3.9M | -0.9M | -3.1M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3839.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3839.HK | Chia Tai Enterprises International Limited(you) | $255M | 97 | STRONG BUY |
| 2161.HK | JBM (Healthcare) Limited | $238M | 99 | STRONG BUY |
| 3613.HK | Beijing Tong Ren Tang Chinese Medicine Company Limited | $697M | 97 | STRONG BUY |
| 2005.HK | SSY Group Limited | $745M | 80 | STRONG BUY |
| 0570.HK | China Traditional Chinese Medicine Holdings Co. Limited | $912M | 76 | BUY |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $83M | 72 | BUY |
| 3320.HK | China Resources Pharmaceutical Group Limited | $3.6B | 97 | STRONG BUY |
| 0867.HK | China Medical System Holdings Limited | $3.2B | 87 | STRONG BUY |
| 3933.HK | The United Laboratories International Holdings Limited | $2.0B | 75 | BUY |
| 0013.HK | HUTCHMED (China) Limited | $1.7B | 58 | HOLD |
Peer medians: ROE 9.0% · P/E 9.4x · Gross margin 41.6%